請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40589
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 阮麗蓉(Li-Jung Juan) | |
dc.contributor.author | Kai-Lin Peng | en |
dc.contributor.author | 彭凱琳 | zh_TW |
dc.date.accessioned | 2021-06-14T16:52:23Z | - |
dc.date.available | 2018-08-01 | |
dc.date.copyright | 2008-08-08 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-30 | |
dc.identifier.citation | An, W., Kim, J., and Roeder, R. G. (2004). Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117, 735-748.
Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T., and Brechot, C. (1997). Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94, 1200-1205. Bauer, U. M., Daujat, S., Nielsen, S. J., Nightingale, K., and Kouzarides, T. (2002). Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep 3, 39-44. Berger, S. L. (2007). The complex language of chromatin regulation during transcription. Natue 447, 407-412. Bernat, A., Avvakumov, N., Mymryk, J. S., and Banks, L. (2003). Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22, 7871-7881. Berthet, C., Guéhenneux, F., Revol, V., Samarut, C., Lukaszewicz, A., Dehay, C., Dumontet, C., Magaud, J. P., and Rouault, J. P. (2003). Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects. Genes Cells 7, 29-39. Chakravarti, D., Ogryzko, V., Kao, H. Y., Nash, A., Chen, H., Nakatani, Y., and Evans, R. M. (1999). A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96, 393-403. Chen, C. M., You, L. R., Hwang, L. H., and Lee, Y. H. (1997). Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol 71, 9417-9426. Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S. M., Schurter, B. T., Aswad, D. W., and Stallcup, M. R. (1999). Regulation of transcription by a protein methyltransferase. Science 284, 2174-2177. Cheng, D., Côté, J., Shaaban, S., and Bedford, M. T. (2007). The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol Cell 25, 71-83. Cheng, P. L., Chang, M. H., Chao, C. H., and Wu Lee, Y. H. (2004). Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Oncogene 23, 7821-7838. Chevillard-Briet, M., Trouche, D., and Vandel, L. (2002). Control of CBP co-activating activity by arginine methylation. EMBO J 21, 5457-5466. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., and Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362. Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K., Tempst, P., Prives, C., Gamblin, S. J., et al. (2004). Regulation of p53 activity through lysine methylation. Nature 432, 353-360. Davie, J. R., and Murphy, L. C. (1990). Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry 29, 4752-4757. Deng, W. G., Zhu, Y., and Wu, K. K. (2003). Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J Biol Chem 278, 4770-4777. Dubourdeau, M., Miyamura, T., Matsuura, Y., Alric, L., Pipy, B., and Rousseau, D. (2002). Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta. J Hepatol 37, 486-492. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825. Fukuda, K., Tsuchihara, K., Hijikata, M., Nishiguchi, S., Kuroki, T., and Shimotohno, K. (2001). Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli. Hepatology 33, 159-165. Giambartolomei, S., Covone, F., Levrero, M., and Balsano, C. (2001). Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. Oncogene 20, 2606-2610. Gomez-Gonzalo, M., Benedicto, I., Carretero, M., Lara-Pezzi, E., Maldonado-Rodriguez, A., Moreno-Otero, R., Lai, M. M., and Lopez-Cabrera, M. (2004). Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity. Virology 328, 120-130. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M., and Rice, C. M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385-1395. Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-352. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816. Herrmann, F., Lee, J., Bedford, M. T., and Fackelmayer, F. O. (2005). Dynamics of human protein arginine methyltransferase 1(PRMT1) in Vivo. J Biol Chem 280, 38005-38010. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991). p53 mutations in human cancers. Science 253, 49-53. Hsieh, T. Y., Matsumoto, M., Chou, H. C., Schneider, R., Hwang, S. B., Lee, A. S., and Lai, M. M. (1998). Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem 273, 17651-17659. Hsu, C. H., Chang, M. D., Tai, K. Y., Yang, Y. T., Wang, P. S., Chen, C. J., Wang, Y. H., Lee, S. C., Wu, C. W., and Juan, L. J. (2004). HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. Embo J 23, 2269-2280. Huang, J., Kent, J. R., Placek, B., Whelan, K. A., Hollow, C. M., Zeng, P. Y., Fraser, N. W., and Berger, S. L. (2006). Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J Virol 12, 5740-5746. Jenuwein, T., and Allis, C. D. (2001). Translating the histone code. Science 293, 1074-1080. Kao, C. F., Chen, S. Y., Chen, J. Y., and Wu Lee, Y. H. (2004). Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23, 2472-2483. Komyod, W., Bauer, U. M., Heinrich, P. C., Haan, S., and Behrmann, I. (2005). Are STATS arginine-methylated? J Biol Chem 280, 21700-21705. Kornberg, R. D., and Lorch, Y. (1999). Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285-294. Kouskouti, A., Scheer, E., Staub, A., Tora, L., and Talianidis, I. (2004). Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 14, 175-182. Krause, C. D., Yang, Z. H., Kim, Y. S., Lee, J. H., Cook, J. R., and Pestka, S. (2007). Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol Ther 113, 50-87. Kurash, J. K., Lei, H., Shen, Q., Marston, W. L., Granda, B. W., Fan, H., Wall, D., Li, E., and Gaudet, F. (2008). Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell, 392-400. Lauer, G. M., and Walker, B. D. (2001). Medical Progress: Hepatitis C Virus Infection. N Engl J Med 345, 41-52. Lee, S., Park, U., and Lee, Y. I. (2001). Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites. Virology 283, 167-177. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331. Li, Y. J., Stallcup, M. R., and Lai, M. M. (2004). Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol 78, 13325-13334. Lim, S. P., and Garzino-Demo, A. (2000). The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. J Virol 74, 1632-1640. Lin, W. J., Gary, J. D., Yang, M. C., Clarke, S., and Herschman, H. R. (1996). The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271, 15034-15044. Liu, Q., Tackney, C., Bhat, R. A., Prince, A. M., and Zhang, P. (1997). Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 71, 657-662. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., and Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113. Lu, W., Lo, S. Y., Chen, M., Wu, K., Fung, Y. K., and Ou, J. H. (1999). Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264, 134-141. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-260. Mai, R. T., Yeh, T. S., Kao, C. F., Sun, S. K., Huang, H. H., and Wu Lee, Y. H. (2006). Hepatitis C virus core protein recruits nucleolar phosphoprotein B23 and coactivator p300 to relieve the repression effect of transcriptional factor YY1 on B23 gene expression. Oncogene 25, 448-462. Matsumoto, M., Hsieh, T. Y., Zhu, N., VanArsdale, T., Hwang, S. B., Jeng, K. S., Gorbalenya, A. E., Lo, S. Y., Ou, J. H., Ware, C. F., and Lai, M. M. (1997). Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 71, 1301-1309. McKinney, K., Mattia, M., Gottifredi, V., and Prives, C. (2004). p53 Linear Diffusion along DNA Requires Its C Terminus. Mol Cell 16, 413-424. Moradpour, D., Englert, C., Wakita, T., and Wands, J. R. (1996). Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222, 51-63. Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., and Koike, K. (1998). The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4, 1065-1067. Moriya, K., Yotsuyanagi, H., Shintani, Y., Fujie, H., Ishibashi, K., Matsuura, Y., Miyamura, T., and Koike, K. (1997). J Gen Virol 78, 1527-1531. Nelson, P. J., Kim, H. T., Manning, W. C., Goralski, T. J., and Krensky, A. M. (1993). Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151, 2601-2612. Nishioka, K., Chuikov, S., Sarma, K., Erdjument-Bromage, H., Allis, C. D., Tempst, P., and Reinberg, D. (2002). Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 16, 479-489. Nowak, S. J., and Corces, V. G. (2004). Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20, 214-220. Okamoto, S., Mukaida, N., Yasumoto, K., Rice, N., Ishikawa, Y., Horiguchi, H., Murakami, S., and Matsushima, K. (1994). The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem 269, 8582-8589. Otsuka, M., Kato, N., Lan, K., Yoshida, H., Kato, J., Goto, T., Shiratori, Y., and Omata, M. (2000). Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 275, 34122-34130. Patel, D., Huang, S. M., Baglia, L. A., and McCance, D. J. (1999). The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. Embo J 18, 5061-5072. Pawlak, M. R., Scherer, C. A., Chen, J., Roshon, M. J., and Ruley, H. E. (2000). Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 20, 4859-4869. Ray, R. B., Steele, R., Meyer, K., and Ray, R. (1998). Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208, 331-336. Rezai-Zadeh, N., Zhang, X., Namour, F., Fejer, G., Wen, Y. D., Yao, Y. L., Gyory, I., Wright, K., and Seto, E. (2003). Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev 17, 1019-1029. Rho, J., Choi, S., Seong, Y. R., Choi, J., and Im, D. S. (2001). The arginine-1493 residue in QRRGRTGR1493G motif IV of the hepatitis C virus NS3 helicase domain is essential for NS3 protein methylation by the protein arginine methyltransferase 1. J Virol 75, 8031-8044. Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M., Nainan, O., et al. (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143, 2493-2503. Robin-Lespinasse, Y., Sentis, S., Kolytcheff, C., Rostan, M. C., Corbo, L., and Le Romancer, M. (2007). hCAF1, a new regulator of PRMT1-dependent arginine methylation. J Cell Science 120, 638-647 Santolini, E., Migliaccio, G., and La Monica, N. (1994). Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68, 3631-3641. Selby, M. J., Choo, Q. L., Berger, K., Kuo, G., Glazer, E., Eckart, M., Lee, C., Chien, D., Kuo, C., and Houghton, M. (1993). Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 74 ( Pt 6), 1103-1113. Shrivastava, A., Manna, S. K., Ray, R., and Aggarwal, B. B. (1998). Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol 72, 9722-9728. Somasundaram, K., and El-Deiry, W. S. (1997). Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047-1057. Sterner, D. E., and Berger, S. L. (2000). Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64, 435-459. Review. Sun, C. A., Chen, H. C., Lu, C. F., You, S. L., Mau, Y. C., Ho, M. S., Lin, S. H., and Chen, C. J. (1999). Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 59, 290-296. Suzuki, R., Sakamoto, S., Tsutsumi, T., Rikimaru, A., Tanaka, K., Shimoike, T., Moriishi, K., Iwasaki, T., Mizumoto, K., Matsuura, Y., et al. (2005). Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol 79, 1271-1281. Tang, J., Kao, P. N., and Herschman, H. R. (2000). Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by Interleukin enhancer-binding factor 3. J Biol Chem 275, 19866 - 19876 Teyssier, C., Chen, D., and Stallcup, M. R. (2002). Requirement for multiple domains of the protein arginine methyltransferase CARM1 in its transcriptional coactivator function. J Biol Chem 277, 46066-46072. Teyssier, C., Ma, H., Emter, R., Kralli, A., and Stallcup, M. R. (2005). Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation. Genes Dev 19, 1466-1473. Torres-Padilla, M. E., Parfitt, D. E., Kouzarides, T., and Zernicka-Goetz, M. (2007). Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 445, 214-218. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G., Mizokami, M., et al. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796. Wang, H., Cao, R., Xia, L., Erdjument-Bromage, H., Borchers, C., Tempst, P., and Zhang, Y. (2001a). Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 8, 1207-1217. Wang, H., Huang, Z. Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P., and Zhang, Y. (2001b). Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293, 853-857. Watashi, K., and Shimotohno, K. (2003). The roles of hepatitis C virus proteins in modulation of cellular functions: a novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors. Cancer Sci 94, 937-943. Wysocka, J., Allis, C. D., and Coonrod, S. (2006). Histone arginine methylation and its dynamic regulation. Front Biosci 11, 344-355. Yadav, N., Lee, J., Kim, J., Shen, J., Hu, M. C., Aldaz, C. M., and Bedford, M. T. (2003). Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc Natl Acad Sci U S A 100, 6464-6468. Yasui, K., Wakita, T., Tsukiyama-Kohara, K., Funahashi, S. I., Ichikawa, M., Kajita, T., Moradpour, D., Wands, J. R., and Kohara, M. (1998). The native form and maturation process of hepatitis C virus core protein. J Virol 72, 6048-6055. Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K., Sata, M., Kohara, M., and Yoshimura, A. (2002). Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 196, 641-653. You, L. R., Chen, C. M., Yeh, T. S., Tsai, T. Y., Mai, R. T., Lin, C. H., and Lee, Y. H. (1999). Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol 73, 2841-2853. Zhang, Y., and Reinberg, D. (2001). Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15, 2343-2360. Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C., and Lai, M. M. (1998). Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72, 3691-3697. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40589 | - |
dc.description.abstract | Table of Contents
List of abbreviations…………………………………………...…………..1 中文摘要….………………………………………………..………………2 Abstract………………………………………...…………………………..4 Introduction………………………...………………………………………6 I. The contribution of HCV core protein to HCV pathogenesis………...6 I-1. Hepatitis C virus is an important human pathogen………………6 I-2. HCV core protein isoforms………………………………………7 I-3. HCV core protein interacts with cellular proteins……………….8 I-4. HCV core protein-mediated gene regulation………………….....9 II. Post-translational modification of histone proteins………………...10 II-1. Histone methylation and histone methyltransferases…………..11 II-1-1. Protein arginine methyltransferase 1 (PRMT1)…...………12 II-1-2. Coactivator-associated arginine methyltransferase 1 (CARM1)……………………………………..…………14 II-1-3. SET domain-containing lysine methyltransferase 9 (SET9)…………………………………………………...15 III. Histone modifiers are regulated by viral proteins………………….16 Preliminary Results……………………………………………………….18 Materials and Methods……………………………………………………22 Cell lines and DNA transfections……………………………………...22 Plasmids and antibodies………………………………………………..22 Reporter assay……………………………….…………………………24 Immunofluorescence assay……………………….……………………25 Immunoprecipitation/co-immunoprecipitation assay……………….…26 Western analysis….……………..……………………………………..27 IP-Mass spectrometry............………………………………………….28 In gel digestion…….............................................…………………...…28 Chromatin immunoprecipitation (ChIP)……………………………….29 Results…………………………………………………………...………..31 Interaction of HCV core protein and endogenous CARM1 and PRMT1 in vivo…………………………………………………………………..31 Nuclear localization of HCV core protein……………………………..31 Recruitment of HCV core protein to the p21 promoter did not impair p53 binding…………………………………………………...………..33 HCV core protein-mediated repression of p21 promoter activity.……34 Inhibition of CARM1- and PRMT1-induced p21 promoter activity and active histone modification by HCV core protein……………………35 HCV core protein-mediated inhibition of the promoter activitiy of NF-κB targeted genes……...………………………………..………..37 Methylation of HCV core protein……………………………………...38 Discussion…...……………………………………………………………40 References……...…………………………………………………………45 Figure 1. HCV core protein interacted with CARM1, PRMT1, but not SET9 in vivo………………………………………………………………55 Figure 2. Cellular distribution of HCV core protein……………………..56 Figure 3. Cellular distribution of CARM1, PRMT1 and SET9…………..57 Figure 4. Effects of HCV core protein on p21 promoter activity….……..58 Figure 5. HCV core protein repressed the CARM1- and PRMT1-enhanced p21 promoter activities…………………………………………………...59 Figure 6. HCV core protein inhibited the CARM1- and PRMT1-mediated active histone modification pattern on p21 promoter…………...………..61 Figure 7. HCV core protein reduced the promoter activities of NF-κB targeted genes….………………………………………………………….62 Figure 8. HCV core protein was methylated by R-HMTs………………..63 Table 1. Amino acid sequences of HCV core protein c173………………64 Table 2. The R17 residue of HCV core protein c173 was methylated.......64 Supplementary Results….………………………………………………...65 Acknowledgements……………………………………………………….68 | zh_TW |
dc.description.abstract | Posttranslational modification of histone proteins constitutes the histone code which plays an important role in eukaryotic gene expression as well as viral pathogenesis. Previous studies have shown that viral proteins functionally interact with histone acetyltransferases/deacetylases. Whether cellular histone methyltransferases (HMTs) are also targeted by viral oncoproteins remains unclear. Our previous study indicated that the core protein of the hepatitis C virus (HCV) which causes chronic hepatitis, cirrhosis, fibrosis and hepatocellular carcinoma in infected individuals represses core histone methylation by coactivator-associated arginine methyltransferase 1 (CARM1), protein arginine methyltransferase 1 (PRMT1), and SET domain-containing lysine methyltransferase 9 (SET9) in in vitro HMT assays. It prompted us to investigate the relationship between HCV core protein and the three HMTs in vivo. The three HMTs (CARM1, PRMT1 and SET9) are the coactivators of p53, and p21 is the downstream of p53. We used human hepatoma cell line Huh 7 as our study model. We demonstrated that in reporter assays HCV core protein repressed CARM1- and PRMT1-enhanced p21 promoter activities as well as p21 synthesis. In addition, we showed the in vivo interactions between core protein and CARM1 and PRMT1. Using the chromatin-immunoprecipitation (ChIP) analysis, we further demonstrated that (1) core protein was recruited to the p21 promoter, (2) core protein did not affect p53 binding to the p21 promoter and (3) inhibited histone H3 acetylation and H3K4 mono-methylation, the active histone modification pattern. Furthermore, we unraveled that core protein 191 repressed promoter activities of four kinds of NF-κB target genes in reporter assay, and R17 site of core protein c173 was methylated. Taken together, our results indicate that HCV core protein inhibits HMT activities on core histones in vivo, which in turn resulted in the inhibition of the function of p53 and NF-κB. | en |
dc.description.provenance | Made available in DSpace on 2021-06-14T16:52:23Z (GMT). No. of bitstreams: 1 ntu-97-R95448007-1.pdf: 2782573 bytes, checksum: 35739a195634d3e7fbca1eca24681f99 (MD5) Previous issue date: 2008 | en |
dc.language.iso | en | |
dc.title | C型肝炎病毒核心蛋白調控組蛋白甲基化酵素活性之功能性研究 | zh_TW |
dc.title | Functional Regulation of Histone Methyltransferase Activity by Hepatitis C Virus Core Protein | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 呂勝春(Sheng-Chung Lee),施修明(Hsiu-Ming Shih),陳士隆(Steve S.L. Chen) | |
dc.subject.keyword | C型肝炎病毒核心蛋白,染色質修飾蛋白,組蛋白甲基化酵素,CARM1,PRMT1,SET9, | zh_TW |
dc.subject.keyword | HCV core protein,histone methyltransferase (HMT),CARM1,PRMT1,SET9, | en |
dc.relation.page | 68 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-31 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
顯示於系所單位: | 分子醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 2.72 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。